IJMS | Free Full-Text | How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes | BMC Women's Health | Full Text
Disease-free survival curves of luminal type A and B breast cancer. | Download Scientific Diagram
Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden | BMC Cancer | Full Text
:max_bytes(150000):strip_icc()/GettyImages-1164234982-17a305f7dbaf4f4fb29ca25003cde65b.jpg "Luminal A Breast Cancer: Causes, Diagnosis, and Treatment")
Luminal A Breast Cancer: Causes, Diagnosis, and Treatment
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer
Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients | Scientific Reports
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives | Journal of Clinical Oncology
Breast Cancer Subtypes And Prognosis | BCTT
Luminal breast cancer | BCTT
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
Molecular profiles of genomically High Risk ER+ HER2- breast cancer tumors classified as functionally Basal or Luminal B by the BluePrint - Agendia
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study | Scientific Reports
Cancers | Free Full-Text | Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
Luminal B Breast Cancer | Breast Cancer Trials
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Breast Cancer Types | Breast Cancer Trials
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
:max_bytes(150000):strip_icc()/GettyImages-1389278061-ca025a5867e04ce18d7fc1b2ecba8ce2.jpg "Luminal B Breast Cancer: Symptoms, Diagnosis, and More")
Luminal B Breast Cancer: Symptoms, Diagnosis, and More
Triple negative breast cancer therapies nanomedicine - Inside Tx
